The Global CAR-T Therapy Pipeline Analysis Market Report by The Business Research Company covers CAR-T therapy pipeline analysis market drivers and restraints, CAR-T therapy pipeline analysis market size, major players, and the impact of COVID-19 on the CAR-T therapy pipeline analysis market.
The chimeric antigen receptor -T therapy market consists of sales of CAR-T therapy products and related services by entities (organizations, sole traders and partnerships) that develop chimeric antigen receptor (CAR) T-cell therapies to treat blood cancers. CAR-T therapy is type of immunotherapy in which T-cells taken from patient’s blood are modified in a laboratory with the addition of a special protein receptor that grants T-cells the power to recognize as well as kill cancer cells easily, along with infusing the same back into that patient. This special protein receptor, known as chimeric antigen receptor (CAR), attaches to a specific protein on a patient’s cancer cells. The infused cells multiply and prevail in the patient’s body as living drugs.
The financial support provided by different organizations towards CAR-T therapy positively drives the growth of CAR-T therapy market. The global CAR-T therapy pipeline analysis market is expected to grow from $1.08 billion in 2020 to $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 29.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.15 billion in 2025 at a CAGR of 22%.
Request A Sample For The Global CAR-T Therapy Pipeline Analysis Market Report:
Some CAR-T therapy pipeline analysis market trends include companies are conducting clinical trials to assess the ability of CAR-T therapy to treat multiple myeloma. Multiple myeloma is a type of white blood cell cancer where the cancer cells accumulate in the bone marrow and surrounds the healthy blood cells. CAR-T therapy is being tested as a treatment for multiple myeloma. CAR-T cells are modified to target the multiple myeloma causing cells to treat the relapsed or refractory multiple myeloma (RRMM).
Global CAR-T therapy pipeline analysis market segments include:
1) By Target Antigen: CD19, CD22, Others.
2) By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Among these regions, North America is the largest region in the global CAR-T therapy pipeline analysis market, accounting for 61% of the market.
Read More On The CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030 At:
The CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030 is one of a series of new reports from The Business Research Company that provides CAR-T therapy pipeline analysis market overviews, analyzes and forecasts market size, share, CAR-T therapy pipeline analysis market players, CAR-T therapy pipeline analysis market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The CAR-T therapy pipeline analysis market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read CAR-T Therapy Pipeline Analysis Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Novartis AG, Kite Pharma, Pfizer Inc, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Mustang Bio, Immune Therapeutics, Atara Biotherapeutic.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030).
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The CAR-T Therapy Pipeline Analysis Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The CAR-T Therapy Pipeline Analysis Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the CAR-T Therapy Pipeline Analysis Global Market Report 2021: